Valproate Sodium Injection Shortage: Current Availability and Manufacturer Updates

What’s in Shortage

Valproate Sodium Injection (Generic: Valproate Sodium Injection; Brand: VALPROATE SODIUM) is currently listed on the FDA drug shortage database. This medication is an injection dosage form primarily used within the Neurology therapeutic category. The shortage was first posted on December 30, 2020, and the most recent update was provided on February 5, 2026.

Which Manufacturers Are Affected

Currently, the following manufacturer is listed in the database regarding this shortage:

• Fresenius Kabi USA, LLC
  • Status: Available
  • Presentation: Valproate Sodium, Injection, 100 mg/1 mL (NDC 63323-494-05)
  • Notes: The manufacturer advises checking with wholesalers for current inventory.
  • Contact Info: 888-386-1300

Why There’s a Shortage

No specific reason for the shortage of Valproate Sodium Injection was provided in the current FDA report.

What Patients Should Do

If you or a loved one relies on Valproate Sodium Injection, consider the following steps:

1. Consult Your Healthcare Provider: Discuss your treatment plan and any concerns regarding medication availability. Do not make changes to your medication regimen without professional medical advice.
2. Speak with Your Pharmacist: Pharmacists often have the most up-to-date information on local stock and can check with multiple wholesalers to locate available supply.
3. Contact the Manufacturer: You may reach out to Fresenius Kabi USA, LLC directly at 888-386-1300 for specific information regarding their current supply levels.

Disclaimer: This article is for informational purposes only. Patients should always consult with their healthcare provider or pharmacist regarding medical treatments and alternatives.

Source

Information provided by the FDA Drug Shortage Database.